Drug industry
Article Abstract:
The drug industry had a highly profitable year in 1996, although not all companies have reported their final annual results. Profits for the larger multinational companies that are research based are also expected to be good in 1997, as well, even though generic drug companies may have difficulties. Industry earnings through 1999-2001 will be driven mainly by a stream of new drugs. Investors should be cautious when evaluating drug company stocks.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Drug industry
Article Abstract:
The pharmaceutical industry had a superior year in 1995, with many companies reporting revenues and earnings in double digits. Stocks for biotechnology companies increased 80% during the year, and drug stocks appreciated 59% as well. Drug industry earnings are also expected to be in double digits during 1996, outperforming other industries. Consolidation and other factors make drug industry stocks good investments for 1996 and later.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 1996
User Contributions:
Comment about this article or add new information about this topic: